Utilization of herpesviridae as recombinant viral vectors in vaccine development against animal pathogens

This publication has 186 references indexed in Scilit:

• Turkey herpesvirus with an insertion in the UL3-4 region displays an appropriate balance between growth activity and antibody-eliciting capacity and is suitable for the establishment of a recombinant vaccine
  Archives of Virology, 2016
• Correlation of renal tubular epithelial cell–derived interleukin‐18 up‐regulation with disease activity in MRL‐Fas^lpr mice with autoimmune lupus nephritis
  Arthritis & Rheumatism, 2002
• Recombinant feline herpesvirus type 1 expressing Toxoplasma gondii ROP2 antigen inducible protective immunity in cats
  Parasitology Research, 2002
• Protection of Chickens against Very Virulent Infectious Bursal Disease Virus (IBDV) and Marek's Disease Virus (MDV) with a Recombinant MDV Expressing IBDV VP2
  Virology, 1999
• Antigenically Distinct G Glycoproteins of BRSV Strains Share a High Degree of Genetic Homogeneity
  Virology, 1997
• The Equine Herpesvirus 1 IR6 Protein Influences Virus Growth at Elevated Temperature and Is a Major Determinant of Virulence
  Virology, 1996
• Pathogenicity and vaccine efficacy of a thymidine kinase-deficient mutant of feline herpesvirus type 1 in cats
  Archives of Virology, 1996
• Herpesvirus of Turkey Recombinant Viruses Expressing Infectious Bursal Disease Virus (IBDV) VP2 Immunogen Induce Protection against an IBDV Virulent Challenge in Chickens
  Virology, 1995
• Marek's Disease Virus Protein Kinase Gene Identified within the Short Unique Region of the Viral Genome Is Not Essential for Viral Replication in Cell Culture and Vaccine-Induced Immunity in Chickens
  Virology, 1993
• Thymidine kinase-negative bovine herpesvirus type 1 mutant is stable and highly attenuated in calves
  Archives of Virology, 1985